Walgreens Boots Alliance (WBA) reported fourth-quarter earnings of $0.67 per share on revenue of $35.4 billion. Earnings missed analyst expectations of $0.69 per share, but revenue topped estimates of $34.82 billion.

The company attributed the earnings miss to higher costs, including labor and supply chain costs. Walgreens Boots Alliance also said a decline in COVID-19 testing and vaccination revenue impacted it.

Despite the earnings miss, Walgreens Boots Alliance said that it is confident in its long-term growth prospects. The company is investing in its digital capabilities and its retail footprint. Walgreens Boots Alliance is also expanding its healthcare services offerings.

The earnings miss from Walgreens Boots Alliance is a disappointment. Still, it is important to note that the company faces some headwinds, including higher costs and a decline in COVID-19 testing and vaccination revenue.

However, Walgreens Boots Alliance is well-positioned for long-term growth. The company is investing in its digital capabilities and its retail footprint. Walgreens Boots Alliance is also expanding its healthcare services offerings.

Walgreens Boots Alliance reported fourth-quarter earnings that missed estimates, but revenue topped. The company attributed the earnings miss to higher costs and a decline in COVID-19 testing and vaccination revenue. Despite the earnings miss, Walgreens Boots Alliance said that it is confident in its long-term growth prospects.